TBPH
Theravance Biopharma, Inc.Company with tickers: TBPH
CIK
1583107
CUSIP
G8807B106
Shares Outstanding
51,553,005
13F Activity (30d)
116 filings
113 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year, share counts where the company tagged them, and the buyback program's authorization. Amounts come exclusively from tagged SEC data, so years a company never tagged show no figure.
Program Authorized
$325,000,000
as of 2023-09-30
Remaining Authorization
$30,400,000
as of 2023-09-30
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2024-12-31 | $445,000 | 10-K, filed 2026-03-23 |
| 2023-12-31 | $197,051,000 | 10-K, filed 2025-03-07 |
| 2022-12-31 | $128,830,000 | 10-K, filed 2024-03-01 |